RashmiChughMD

Oncology • Ann Arbor, MI

Hematologic Oncology, Sarcoma

University of Michigan

Join to view full profile

Dr. Chugh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chugh's full profile

Already have an account?

Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Phone+1 734-936-4000

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 2002 - 2005
University of MichiganResidency, Internal Medicine, 1998 - 2002
Washington University in St. Louis School of MedicineClass of 1998

Certifications & Licensure

MI State Medical License 2001 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Start of enrollment: 2005 Jul 01
Completed
Phase 2
Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas Start of enrollment: 2005 Jun 01
Completed
Phase 2
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Start of enrollment: 2008 Jun 01
Completed
Phase 1
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors Start of enrollment: 2011 Jan 03
Completed
Phase 1
Phase 1b Trial of BGJ398/BYL719 in Solid Tumors Start of enrollment: 2013 Oct 01
Completed
Phase 1
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma Start of enrollment: 2014 May 01
Completed
Phase 1
Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia Start of enrollment: 2014 Dec 01
Terminated
Phase 1
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Start of enrollment: 2015 Nov 30
Terminated
Phase 1, Phase 2
A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma Start of enrollment: 2015 Dec 22
Completed
Phase 2
Ribociclib (LEE011) Rollover Study for Continued Access Start of enrollment: 2016 Dec 15
Recruiting
Phase 2
To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue Start of enrollment: 2021 Sep 01
Completed
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

802 citations
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson, Yi-Mi Wu, Pankaj Vats, Fengyun Su, Robert J. Lonigro
Nature Genetics. 2013-12-01
75 citations
SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma
Scott M. Schuetze, J. Kyle Wathen, David R. Lucas, Edwin Choy, Brian L. Samuels
Cancer. 2016-03-15
190 citations
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
Mrinal M. Gounder, Patrick Schöffski, Robin L. Jones, Mark Agulnik, Gregory M. Cote
The Lancet. Oncology. 2020-11-01

Other

Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging
Chugh R, Feng M, Sabel MS
http://www.uptodate.com/contents/breast-sarcoma-epidemiology-risk-factors-clinical-presentation-diag
UpToDate, Wolters Kluwer Health - 2012-11-19
Breast sarcoma: Treatment
Chugh R, Feng M, Sabel MS
http://www.uptodate.com/contents/breast-sarcoma-treatment
UpToDate, Wolters Kluwer Health - 2012-10-05
Phyllodes tumors of the breast
Chugh R, Chakravarthy AB, Grau AM
http://www.uptodate.com/contents/phyllodes-tumors-of-the-breast
UpToDate, Wolters Kluwer Health - 2012-10-18

Press Mentions

Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (Devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, CalifSeptember 27th, 2021
For Ann Arbor Pastor Stacey Duke, and Many Other Patients with Cancer, the Pandemic Feels Far from OverJuly 16th, 2021
Unconditional Love and Radical AcceptanceMarch 24th, 2020